American International Group’s Genetic Technologies Ltd. GENE Stock Holding History

American International Group’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-18	Closed	-$1.84K	–	5202
2015 Q1	$1.84K	Buy	+18	New	+$1.47K	﹤0.01%	4860

Other funds holding GENE

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

American International Group's GENE Position: Q2 2015 in Review

American International Group sold out of Genetic Technologies Ltd. (GENE) in Q2 2015, closing a stake of 18 shares — an estimated $1.84K sold.

American International Group first reported a position in GENE in Q1 2015 and held it in 1 quarter. The position peaked at $1.84K in Q1 2015. 8 funds tracked by Wall St. Rank hold GENE as of Q2 2015.

American International Group reported no remaining Genetic Technologies Ltd. position as of Q2 2015 after selling out during the quarter.
American International Group sold 18 Genetic Technologies Ltd. shares in Q2 2015, an estimated $1.84K.
American International Group first reported a position in Genetic Technologies Ltd. in Q1 2015 and held it in 1 quarter.
American International Group's Genetic Technologies Ltd. position peaked at $1.84K in Q1 2015.
8 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2015.

Based on American International Group's 13F filing for Q2 2015, filed 12 Aug 2015.